{
  "ticker": "ILA",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02966573",
  "id": "02966573",
  "pages": 2,
  "price_sensitive": true,
  "date": "20250707",
  "time": "0933",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250707/pdf/06ljn40799st2m.pdf",
  "summary": "**Trading Halt Request:**  \n- Reason: Pending announcement of an Asset Purchase Agreement with BioCryst Pharmaceuticals, Inc. regarding the Galidesivir program.  \n- Halt duration: Until earlier of market open on 9 July 2025 or announcement release.  \n\n(Boilerplate and non-material details omitted.)",
  "usage": {
    "prompt_tokens": 800,
    "completion_tokens": 68,
    "total_tokens": 868,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-06T23:45:03.971620"
}